Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of a Standard Titration Algorithm Coupled With a Conventional Dietary Intervention or Intensive Dietary Intervention Versus a Standard Titration Algorithm, Alone, in Patients With Type 2 Diabetes Initiating NovoLog® Mix 70/30 Therapy
This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled with dietary intervention to standard titration without dietary intervention.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Novo Nordisk Clinical Trial Call Center
Princeton, New Jersey, United States
Start Date
October 1, 2004
Primary Completion Date
June 1, 2006
Completion Date
June 1, 2006
Last Updated
November 2, 2023
4,877
ACTUAL participants
biphasic insulin aspart
DRUG
dietary regimen
BEHAVIORAL
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07296484